Literature DB >> 23148808

Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study.

Lauren E Edwards1, Briana Mezuk.   

Abstract

OBJECTIVE: Depression is increasingly recognized as a risk factor for type 2 diabetes, and is also commonly comorbid with anxiety. However, few studies have examined whether anxiety is predictive of diabetes risk. The objectives of this study are to examine the prospective relationship between anxiety disorders (generalized anxiety disorder, panic disorder, social phobia, and agoraphobia) and risk of type 2 diabetes over an 11-year period, and to investigate the association between anxiety and risk of diabetes-related complications among those with prevalent type 2 diabetes.
METHODS: Data come from the 1993/6 and 2004/5 waves of the Baltimore Epidemiologic Catchment Area Study (N=1920), a population-based prospective cohort. Anxiety disorders were assessed using the Diagnostic Interview Schedule. The prospective association between anxiety and incident type 2 diabetes was evaluated using a series of nested multivariable logistic regression models.
RESULTS: At baseline, 315 participants (21.8%) had an anxiety disorder. The relationship between anxiety and risk of developing type 2 diabetes was not statistically significant after controlling for demographic characteristics (Odds Ratio (OR): 1.28, 95% Confidence Interval (CI): 0.75, 2.18). There was no relationship between anxiety and diabetes risk after controlling for health behaviors and depression status (OR: 1.00, 95% CI: 0.53, 1.89). There was no significant relationship between anxiety and development of diabetes-related complications among those with prevalent type 2 diabetes (OR: 2.02, 95% CI: 0.61, 6.74).
CONCLUSION: Anxiety disorders are not associated with increased risk of type 2 diabetes or risk of diabetes complications among those who have diabetes.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23148808      PMCID: PMC3499773          DOI: 10.1016/j.jpsychores.2012.09.018

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  37 in total

1.  Short and long sleep are positively associated with obesity, diabetes, hypertension, and cardiovascular disease among adults in the United States.

Authors:  Orfeu M Buxton; Enrico Marcelli
Journal:  Soc Sci Med       Date:  2010-06-16       Impact factor: 4.634

Review 2.  Influence of psychosocial factors and biopsychosocial interventions on outcomes after myocardial infarction.

Authors:  E F Buselli; E M Stuart
Journal:  J Cardiovasc Nurs       Date:  1999-04       Impact factor: 2.083

Review 3.  Human and economic burden of generalized anxiety disorder.

Authors:  Deborah L Hoffman; Ellen M Dukes; Hans-Ulrich Wittchen
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

4.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

5.  Prevalence and incidence of anxiety disorders in diabetic patients: a national population-based cohort study.

Authors:  Chun-Jen Huang; Herng-Chia Chiu; Mei-Hsuan Lee; Shing-Yaw Wang
Journal:  Gen Hosp Psychiatry       Date:  2010-11-23       Impact factor: 3.238

6.  Association of depression and diabetes complications: a meta-analysis.

Authors:  M de Groot; R Anderson; K E Freedland; R E Clouse; P J Lustman
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

7.  A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes.

Authors:  L Fisher; M M Skaff; J T Mullan; P Arean; R Glasgow; U Masharani
Journal:  Diabet Med       Date:  2008-09       Impact factor: 4.359

Review 8.  Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis.

Authors:  Francesco P Cappuccio; Lanfranco D'Elia; Pasquale Strazzullo; Michelle A Miller
Journal:  Diabetes Care       Date:  2009-11-12       Impact factor: 19.112

9.  Depression, anxiety and glucose metabolism in the general dutch population: the new Hoorn study.

Authors:  Vanessa Bouwman; Marcel C Adriaanse; Esther van 't Riet; Frank J Snoek; Jacqueline M Dekker; Giel Nijpels
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

10.  Associations between anxiety, depression, and the metabolic syndrome.

Authors:  Michael R Skilton; Philippe Moulin; Jean-Louis Terra; Fabrice Bonnet
Journal:  Biol Psychiatry       Date:  2007-06-05       Impact factor: 13.382

View more
  13 in total

1.  Relationships of Depression, Anxiety, and Stress with Adherence to Self-Management Behaviors and Diabetes Measures in African American Adults with Type 2 Diabetes.

Authors:  Diane Orr Chlebowy; Catherine Batscha; Nancy Kubiak; Timothy Crawford
Journal:  J Racial Ethn Health Disparities       Date:  2018-05-29

2.  Metformin produces anxiolytic-like effects in rats by facilitating GABAA receptor trafficking to membrane.

Authors:  Jun Fan; Di Li; Hong-Sheng Chen; Jian-Geng Huang; Jun-Feng Xu; Wen-Wen Zhu; Jian-Guo Chen; Fang Wang
Journal:  Br J Pharmacol       Date:  2018-11-29       Impact factor: 8.739

3.  Sex differences in the association between depression, anxiety, and type 2 diabetes mellitus.

Authors:  Ryan T Demmer; Sara Gelb; Shakira F Suglia; Katherine M Keyes; Allison E Aiello; Paolo C Colombo; Sandro Galea; Monica Uddin; Karestan C Koenen; Laura D Kubzansky
Journal:  Psychosom Med       Date:  2015-05       Impact factor: 4.312

4.  Diagnostic criteria for depression in type 2 diabetes: a data-driven approach.

Authors:  Sergio E Starkstein; Wendy A Davis; Milan Dragovic; Violetta Cetrullo; Timothy M E Davis; David G Bruce
Journal:  PLoS One       Date:  2014-11-12       Impact factor: 3.240

5.  Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study.

Authors:  Evan Atlantis; Shima Ghassem Pour; Federico Girosi
Journal:  BMJ Open       Date:  2018-01-23       Impact factor: 2.692

6.  Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta-analysis.

Authors:  K J Smith; S S Deschênes; N Schmitz
Journal:  Diabet Med       Date:  2018-03-25       Impact factor: 4.359

7.  Depression, anxiety, and prevalent diabetes in the Chinese population: findings from the China Kadoorie Biobank of 0.5 million people.

Authors:  Briana Mezuk; Yiping Chen; Canqing Yu; Yu Guo; Zheng Bian; Rory Collins; Junshi Chen; Zengchang Pang; Huijun Wang; Richard Peto; Xiangsan Que; Hui Zhang; Zhongwen Tan; Kenneth S Kendler; Liming Li; Zhengming Chen
Journal:  J Psychosom Res       Date:  2013-10-05       Impact factor: 3.006

8.  Excess risk of chronic physical conditions associated with depression and anxiety.

Authors:  Rituparna Bhattacharya; Chan Shen; Usha Sambamoorthi
Journal:  BMC Psychiatry       Date:  2014-01-16       Impact factor: 3.630

Review 9.  Psychosocial Factors in Diabetes and Cardiovascular Risk.

Authors:  Ruth A Hackett; Andrew Steptoe
Journal:  Curr Cardiol Rep       Date:  2016-10       Impact factor: 2.931

10.  The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II.

Authors:  Wendy A Davis; David G Bruce; Milan Dragovic; Timothy M E Davis; Sergio E Starkstein
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.